A peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice

Experimental Lung Research

Volumn 32, Issue 1-2, 2006, Pages 43-53

  Gee, Young Suh ^a   Hyoung, Suk Ham ^a   Lee, Shin Hye ^a   Jae, Chul Choi ^a   Koh, Won Jung ^a   Kim, Soo Youl ^b   Lee, Jongmin ^b   Han, Joungho ^a   Hong, Pyo Kim ^c   Choi, Augustine M K ^c   O, Jung Kwon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Neutrophil; Phospholipase A2

Indexed keywords

LIPOPOLYSACCHARIDE; LYSYLVALYLLEUCYLASPARTYLGLYCYLGLUTAMINYLASPARTYLPROLINE; OCTAPEPTIDE; OCTAPEPTIDE R2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVITY; INFLAMMATION; INHALATION; LUNG HOMOGENATE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING;

ADMINISTRATION, INHALATION; ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; PEPTIDE FRAGMENTS; PNEUMONIA; RNA, MESSENGER; TRANSGLUTAMINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646711922     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140600691514     Document Type: Article

References (30)

1. Fesus L, Piacentini M: Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci. 2002;27:534-539.
2. 2 dramatically increases its catalytic activity. J Biol Chem. 1990;265:17180- 17188.
3. Jeon JH, Choi KH, Cho SY, Kim CW, Shin DM, Kwon JC, Song KY, Park SC, Kim IG: Transglutaminase 2 inhibits Rb binding of human paillomavirus E7 by incorporating polyamine. EMBO J. 2003;22:5273-5282.
4. Aeschlimann D, Thomazy V: Protein crosslinking in assembly and remodeling of extracellular matrices: the role of transglutaminases. Connect Tissue Res. 2000;41:1-27.
5. Aeschlimann D, Paulsson M: Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J Biol Chem. 1991;266:15308-15317.
6. Fesus L, Davies PJ, Piacentini M: Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol. 1991;56:170-177.
7. Griffin M, Smith LL, Wynne J: Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol. 1979;60:653-661.
8. Sohn J, Kim TI, Yoon YH, Kim JY, Kim SY: Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest. 2003;111:121-128.
9. Bruce SE, Bjarnason I, Peters TJ: Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci (Lond). 1985;68:573-579.
10. D'Argenio G, Biancone L, Cosenza V, Della Valle N, D'Armiento FP, Boirivant M, Pallone F, Mazzacca G: Transglutaminases in Crohn's disease. Gut. 1995;37:690-695.
11. Choi YC, Park GT, Kim TS, Sunwoo IN, Steinert PM, Kim SY: Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2. J Biol Chem. 2000;275:8703-8710.
12. Murtaugh MP, Arend WP, Davies PJA: Induction of tissue transglutaminase in human peripheral blood monocytes. J Exp Med. 1984;159:114-125.
13. Harris LK, Pabst MJ, Johnston RB: Increased transglutaminase activity in elicited and activated macrophages: relationship to production of superoxide anion. J Leukoc Biol. 1984;36:719-727.
14. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, Choi KH, Park SC, Kim IG: Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation. Implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem. 2004;279:15032-15039.
15. Ishitani K, Ogawa S, Suzuki M: Influence of arachidonate metabolism on enhancement of intracellular transglutaminase activity in peritoneal macrophages. J Biochem (Tokyo). 1998;104:397-402.
16. Bowness JM, Tarr AH: Increase in transglutaminase and its extracellular products in response to an inflammatory stimulus by lipopolysaccharide. Mol Cell Biochem. 1997;169:157-163.
17. Akimov SS, Belkin AM: Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood. 2001;98:1567-1576.
18. + T cell transendothelial migration. J Immunol. 2003;171:3179-3186.
19. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
20. 2. Structural and functional changes. Am Rev Respir Dis. 1991;143:1102-1109.
21. 2 synthesis. J Immunol. 1997;159:391-400.
22. 2. Nat Immunol. 2000;1:42-46.
23. 2 activities are increased in human adult respiratory distress syndrome. Am J Physiol. 1995;269:L109-L118.
24. 2 inhibitors. Nat Immunol. 2000;1:13-15.
25. Zhang Z, Vezza R, Plappert T, McNamara P, Lawson JA, Austin S, Pratico D, Sutton MS, FitzGerald GA: COX-2 dependent cardiac failure in Gh/tTG transgenic mice. Circ Res. 2003;92:1153-1161.
26. Lee J, Kim YS, Choi DH, Bang MS, Han TR, Job TH, Kim SY: Transglutaminase 2 induces nuclear factor-κB activation via a novel pathway in BV-2 microglia. J Biol Chem. 2004;279:53725-53735.
27. Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM: Tissue-transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Biol Chem. 2003;278:391-399.
28. Tucholski J, Johnson GVW: Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. J Biol Chem. 2003;278:26838-26843.
29. Kim JH, Nam KH, Kwon OS, Kim IG, Bustin M, Choy HE, Park SC: Histone cross-linking by transglutaminase. Biochem Biophy Res Commun. 2002;293:1453-1457.
30. 2 activation by transglutaminase. Int Immunopharmacol. 2006;6:300-303.